Urinary metabolomics analysis identifies key biomarkers of different stages of nonalcoholic fatty liver disease

AIM: To identify a panel of biomarkers that can distinguish between non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH), and explore molecular mechanism involved in the process of developing NASH from NAFLD. METHODS: Biomarkers may differ during stages of NAFLD. Urine...

Descripción completa

Detalles Bibliográficos
Autores principales: Dong, Shu, Zhan, Zong-Ying, Cao, Hong-Yan, Wu, Chao, Bian, Yan-Qin, Li, Jian-Yuan, Cheng, Gen-Hong, Liu, Ping, Sun, Ming-Yu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2017
Materias:
Clinical Trials Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5403757/
https://www.ncbi.nlm.nih.gov/pubmed/28487615
http://dx.doi.org/10.3748/wjg.v23.i15.2771

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5403757/
https://www.ncbi.nlm.nih.gov/pubmed/28487615
http://dx.doi.org/10.3748/wjg.v23.i15.2771

Ejemplares similares